|Bid||1.0200 x 2900|
|Ask||1.0300 x 4000|
|Day's Range||1.0100 - 1.0500|
|52 Week Range||0.2400 - 1.9400|
|Beta (5Y Monthly)||3.52|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar. 24, 2021 - Mar. 29, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||2.63|
NovaBay Pharmaceuticals announces its proprietary hypochlorous acid solution has received EPA approval for SARS-CoV-2 kill claim.
NovaBay Pharmaceuticals Expands Avenova’s Geographic Reach to Australia with New Exclusive Distribution Agreement
NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) reports financial results for the three and nine months ended September 30, 2020 and provides a business update.